Ad is loading...
NVRO
Price
$4.11
Change
-$0.15 (-3.52%)
Updated
Dec 4, 03:20 PM (EDT)
76 days until earnings call
TRIB
Price
$1.01
Change
-$0.08 (-7.34%)
Updated
Dec 4, 03:19 PM (EDT)
Ad is loading...

NVRO vs TRIB

Header iconNVRO vs TRIB Comparison
Open Charts NVRO vs TRIBBanner chart's image
NEVRO
Price$4.11
Change-$0.15 (-3.52%)
Volume$205
CapitalizationN/A
Trinity Biotech
Price$1.01
Change-$0.08 (-7.34%)
Volume$1.6K
CapitalizationN/A
NVRO vs TRIB Comparison Chart
Loading...
NVRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRIB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
NVRO vs. TRIB commentary
Dec 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVRO is a StrongBuy and TRIB is a StrongSell.

COMPARISON
Comparison
Dec 05, 2024
Stock price -- (NVRO: $4.14 vs. TRIB: $1.03)
Brand notoriety: NVRO and TRIB are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NVRO: 87% vs. TRIB: 67%
Market capitalization -- NVRO: $525.59M vs. TRIB: $14.9M
NVRO [@Medical Specialties] is valued at $525.59M. TRIB’s [@Medical Specialties] market capitalization is $14.9M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVRO’s FA Score shows that 0 FA rating(s) are green whileTRIB’s FA Score has 1 green FA rating(s).

  • NVRO’s FA Score: 0 green, 5 red.
  • TRIB’s FA Score: 1 green, 4 red.
According to our system of comparison, TRIB is a better buy in the long-term than NVRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVRO’s TA Score shows that 5 TA indicator(s) are bullish while TRIB’s TA Score has 3 bullish TA indicator(s).

  • NVRO’s TA Score: 5 bullish, 5 bearish.
  • TRIB’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, NVRO is a better buy in the short-term than TRIB.

Price Growth

NVRO (@Medical Specialties) experienced а -9.61% price change this week, while TRIB (@Medical Specialties) price change was -7.62% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.09%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was +0.69%.

Reported Earning Dates

NVRO is expected to report earnings on Feb 19, 2025.

TRIB is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Medical Specialties (+0.09% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVRO($526M) has a higher market cap than TRIB($14.9M). NVRO has higher P/E ratio than TRIB: NVRO (147.06) vs TRIB (33.00). TRIB YTD gains are higher at: -51.981 vs. NVRO (-80.762). TRIB has higher annual earnings (EBITDA): -26.34M vs. NVRO (-78.31M). NVRO has more cash in the bank: 323M vs. TRIB (6.58M). TRIB has less debt than NVRO: TRIB (67.3M) vs NVRO (216M). NVRO has higher revenues than TRIB: NVRO (425M) vs TRIB (71.4M).
NVROTRIBNVRO / TRIB
Capitalization526M14.9M3,530%
EBITDA-78.31M-26.34M297%
Gain YTD-80.762-51.981155%
P/E Ratio147.0633.00446%
Revenue425M71.4M595%
Total Cash323M6.58M4,910%
Total Debt216M67.3M321%
FUNDAMENTALS RATINGS
NVRO vs TRIB: Fundamental Ratings
NVRO
TRIB
OUTLOOK RATING
1..100
353
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
95100
PRICE GROWTH RATING
1..100
9294
P/E GROWTH RATING
1..100
9821
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRIB's Valuation (55) in the Medical Specialties industry is in the same range as NVRO (83). This means that TRIB’s stock grew similarly to NVRO’s over the last 12 months.

TRIB's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVRO (100). This means that TRIB’s stock grew similarly to NVRO’s over the last 12 months.

NVRO's SMR Rating (95) in the Medical Specialties industry is in the same range as TRIB (100). This means that NVRO’s stock grew similarly to TRIB’s over the last 12 months.

NVRO's Price Growth Rating (92) in the Medical Specialties industry is in the same range as TRIB (94). This means that NVRO’s stock grew similarly to TRIB’s over the last 12 months.

TRIB's P/E Growth Rating (21) in the Medical Specialties industry is significantly better than the same rating for NVRO (98). This means that TRIB’s stock grew significantly faster than NVRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVROTRIB
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
71%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
NVRO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TRIB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYRA0.21N/A
+1.33%
Lyra Therapeutics
MBCN31.160.37
+1.20%
Middlefield Banc Corp
VC95.760.65
+0.68%
Visteon Corp
NTRS108.77-0.57
-0.52%
Northern Trust Corp
AVO12.73-0.47
-3.56%
Mission Produce

NVRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVRO has been loosely correlated with INSP. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NVRO jumps, then INSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVRO
1D Price
Change %
NVRO100%
-2.82%
INSP - NVRO
47%
Loosely correlated
+2.62%
AZTA - NVRO
47%
Loosely correlated
-0.09%
CRL - NVRO
46%
Loosely correlated
+0.03%
NVST - NVRO
39%
Loosely correlated
-6.50%
TNDM - NVRO
39%
Loosely correlated
-3.27%
More

TRIB and

Correlation & Price change

A.I.dvisor tells us that TRIB and NVRO have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRIB and NVRO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRIB
1D Price
Change %
TRIB100%
-5.50%
NVRO - TRIB
31%
Poorly correlated
-2.82%
RGEN - TRIB
28%
Poorly correlated
+0.40%
NVCR - TRIB
26%
Poorly correlated
-4.20%
SERA - TRIB
23%
Poorly correlated
-0.93%
COO - TRIB
23%
Poorly correlated
+1.64%
More